ES2196737T3 - Asociacion de un retinoide con un derivado de histidina. - Google Patents

Asociacion de un retinoide con un derivado de histidina.

Info

Publication number
ES2196737T3
ES2196737T3 ES99401133T ES99401133T ES2196737T3 ES 2196737 T3 ES2196737 T3 ES 2196737T3 ES 99401133 T ES99401133 T ES 99401133T ES 99401133 T ES99401133 T ES 99401133T ES 2196737 T3 ES2196737 T3 ES 2196737T3
Authority
ES
Spain
Prior art keywords
association
retinoid
histidine derivative
vitamin
histidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99401133T
Other languages
English (en)
Inventor
Boudiaf Boussouira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2196737T3 publication Critical patent/ES2196737T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a la asociación de al menos un retinoide elegido entre: la vitamina A (o retinol) y los precursores bioconvertibles de la vitamina A, y al menos un derivado de histidina; las composiciones cosméticas que comprenden tal asociación; la utilización de al menos un derivado de histidina para mejorar la estabilidad de una composición cosmética que comprende un retinoide.
ES99401133T 1998-05-26 1999-05-07 Asociacion de un retinoide con un derivado de histidina. Expired - Lifetime ES2196737T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9806603A FR2779060B1 (fr) 1998-05-26 1998-05-26 Association d'un retinoide avec un derive d'histidine

Publications (1)

Publication Number Publication Date
ES2196737T3 true ES2196737T3 (es) 2003-12-16

Family

ID=9526710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99401133T Expired - Lifetime ES2196737T3 (es) 1998-05-26 1999-05-07 Asociacion de un retinoide con un derivado de histidina.

Country Status (9)

Country Link
US (1) US6358514B1 (es)
EP (1) EP0972511B1 (es)
JP (1) JP3095741B2 (es)
KR (1) KR100332260B1 (es)
BR (1) BR9901955A (es)
CA (1) CA2272840A1 (es)
DE (1) DE69906633T2 (es)
ES (1) ES2196737T3 (es)
FR (1) FR2779060B1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
AU782821B2 (en) * 2000-01-19 2005-09-01 Geoffrey Walter Grigg Treatment of UV induced immunosuppression
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
FR2815252B1 (fr) * 2000-10-17 2002-12-20 Oreal Composition, notamment cosmetique, renfermant du retinol et un compose capable de filtrer le rayonnement uva
FR2815857B1 (fr) * 2000-10-30 2003-02-14 Oreal Composition, notamment cosmetique, renfermant un retinoide et une silicone benzotriazole
US20040057974A1 (en) * 2002-08-06 2004-03-25 Naina Sachdev Antiwrinkle composition and age reversal complex
JP2007526218A (ja) * 2003-06-04 2007-09-13 エバーサイツ， リミテッド ライアビリティー カンパニー 新規な皮膚科学的組成物関連応用
WO2006060548A2 (en) * 2004-12-02 2006-06-08 Ebersytes, Llc Novel dermatological composition using bio-activating organocatalysts
DE102006042244A1 (de) 2006-09-06 2008-03-27 Henkel Kgaa Verfahren zur molekularen Charakterisierung von Altershaar
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
JP6864005B2 (ja) * 2016-03-21 2021-04-21 シムライズ アーゲー 医薬品

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929840A (en) * 1972-07-14 1975-12-30 Merck & Co Inc Labile esters of ({31 )(cis-1,2-epoxypropyl)phosphonic
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
WO1990006102A1 (en) * 1988-09-28 1990-06-14 Peptide Technology Limited Compound and method for the retardation of collagen cross-linking
US5126261A (en) * 1989-04-12 1992-06-30 Board Of Regents, The University Of Texas System High calcium chemically defined culture medium
EP0500332B1 (en) * 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
US5441740A (en) * 1994-05-06 1995-08-15 Longevity Network. Ltd. Cosmetic composition containing alpha hydroxyacids, salicyclic acid, and enzyme mixture of bromelain and papain
FR2756565B1 (fr) 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
FR2775973B1 (fr) 1998-03-13 2000-06-23 Oreal Nouveaux derives d'histidine, procede de preparation et utilisations

Also Published As

Publication number Publication date
DE69906633T2 (de) 2004-03-25
JP2000007560A (ja) 2000-01-11
CA2272840A1 (fr) 1999-11-26
FR2779060A1 (fr) 1999-12-03
BR9901955A (pt) 2000-06-06
KR100332260B1 (ko) 2002-04-12
JP3095741B2 (ja) 2000-10-10
KR19990088439A (ko) 1999-12-27
FR2779060B1 (fr) 2003-05-02
EP0972511A1 (fr) 2000-01-19
EP0972511B1 (fr) 2003-04-09
US6358514B1 (en) 2002-03-19
DE69906633D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
ES2172092T3 (es) Asociacion de un retinoide con un polimero poliaminado.
ES2109062T3 (es) Composiciones cosmeticas que contienen un compuesto lipidico de tipo ceramida y un peptido de una cadena grasa, y sus utilizaciones.
ES2185124T3 (es) Composiciones de teñido de las fibras queratinicas que contienen derivados de indazoles de amina y procedimiento de teñido.
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
MX9306986A (es) Composiciones farmaceuticas a base de taxoides.
HN2001000146A (es) Derivados de pirazol
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
ES2188147T3 (es) Anti-irritantes en composiciones cosmeticas.
MX9302244A (es) Composicion de gel acuoso de retinoides.
ES2185241T3 (es) Utilizacion de composiciones cosmeticas que contienen al menos una uxina.
ATE229802T1 (de) Zusammenstellung aus gemischten cyanoacrylatestern
ES2178298T3 (es) Compuestos anti-inflamatorios.
TR200000782T2 (tr) Resorsinol türevleri.
BR0215405A (pt) Composições e processos de uso de collajolie
ES2184836T3 (es) Composiciones que contienen derivados de azol para aplicacion topica en la piel.
DE59902865D1 (de) Entzündungshemmende zahnpflegemittel
AR021370A1 (es) Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
ES2160680T3 (es) Utilizacion de un antagonista de sustancia p en una composicion farmaceutica.
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR015945A1 (es) Composiciones de spray para el cabello autofobicas
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.